StevenK.ClintonMDPh.D.

Genitourinary Oncology

Director, Prostate and Genitourinary Oncology Service Line, The James Cancer Hospital, The Ohio State University. Professor of Medicine, The Ohio State University. Program Leader, Molecular Carcinogenesis and Chemoprevention, The Ohio State University Comprehensive Cancer Center.

Join to view full profile

Dr. Clinton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Clinton's full profile

Already have an account?

Office
394 Wiseman Hall
The Ohio State University
Columbus, OH 43210
Phone+1 614-293-7560

Summary

I am an academic Physician-Scientist in the Department of Internal Medicine and Division of Medical Oncology. My clinical program is focused on prostate cancer. Our program provides care across the spectrum of prostate cancer: active surveillance, prostate cancer genetics, multidisciplinary clinic for new diagnosis and therapy of clinically localized disease, metastatic disease, and survivorship issues. For the OSU Comprehensive Cancer Center, I serve as leader of for the Molecular Carcinogenesis and Chemoprevention Program.

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1988 - 1991
University of ChicagoResidency, Internal Medicine, 1984 - 1987
University of Illinois College of MedicineClass of 1984

Certifications & Licensure

OH State Medical License 1998 - 2025
MA State Medical License 1987 - 1999
IL State Medical License 1984 - 1987
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation

Clinical Trials

Effects of Tomato-Soy Juice on Biomarkers in Patients With Prostate Cancer Undergoing Prostatectomy Start of enrollment: 2008 Jan 01
Completed
Phase 1, Phase 2
Retrospective/Prospective Analysis of Surgical Outcomes of Robotic Prostatectomy at The James Start of enrollment: 2008 Sep 23
Active, not recruiting
Not Applicable
Novel 13C Carotenoids for Absorption and Metabolism Studies in Humans Start of enrollment: 2012 Feb 01
Completed
Phase 1, Phase 2
Nutritional Supplements & Complementary/Alternative Medicine by Prostate & Breast Cancer Patients Start of enrollment: 2002 Dec 11
Completed
Aborption and Metabolism of Lyophilized Black Raspberry Food Products in Men With Prostate Cancer Undergoing Surgery Start of enrollment: 2012 Oct 17
Active, not recruiting
Phase 1
Intensive Diet and Exercise or Standard of Care in Improving Physical Function and Quality of Life in Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy Start of enrollment: 2013 May 21
Active, not recruiting
Not Applicable
Biomarker Identification for Bladder Cancer Patients Start of enrollment: 2014 Jan 21
Active, not recruiting
Nutrition and Exercise Trial: Improving Diet and Physical Activity Patterns in Overweight Cancer Survivors Start of enrollment: 2017 Apr 25
Completed
Not Applicable
Soy Bread Diet in Improving Immune Function in Participants With Prostate Cancer Start of enrollment: 2018 Aug 15
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

Analysis of Physical Activity Using Wearable Health Technology in US Adults Enrolled in the All of Us Research Program: Multiyear Observational Study.
Rujul Singh, Macy K Tetrick, James L Fisher, Peter Washington, Jane Yu
Journal of Medical Internet Research. 2024-12-10
Molecular Networking, Docking, and Biological Evaluation of Licarin A fromas a Potential Cancer Chemopreventive Agent.
Peter J Blanco Carcache, Ines Y Castro-Dionicio, Nathan P Mirtallo Ezzone, Eric D Salinas-Arrellano, Joshua Bahar
Molecules. 2024-10-17
Randomized dose-response trial of n-3 fatty acids in hormone receptor negative breast cancer survivors- impact on breast adipose oxylipin and DNA methylation patterns.
David E Frankhouser, Todd DeWess, Isabel F Snodgrass, Rachel M Cole, Sarah Steck
Medrxiv. 2024-09-16

Journal Articles

The Type of Bariatric Surgery Impacts the Risk of Acute Pancreatitis: A Nationwide Study
Sabrena Noria, Bradley Needleman, Emmanuel Ugbarugba, Somashekar G Krishna, Steven K Clinton, Darwin L Conwell, Hisham Hussan, Nature
Cachectic Cancer Patients: Immune to Check-Point Inhibitor Therapy?
Steven Clinton, MD, Clinical Cancer Research

Press Mentions

American Cancer Society Updates Guidelines for Cancer PreventionJune 9th, 2020
Exercise, Diet, Alcohol: New Guidelines Detail Best Ways to Reduce Cancer RiskJune 9th, 2020
Cholesterol-Lowering Statins May Double Risk of Developing DiabetesApril 28th, 2020
Join now to see all

Grant Support

Novel 13-C Tomato Carotenoids For Absorption And Metabolism Studies In HumansNational Center For Complementary &Alternative Medicine2010–2011
Tomato-Soy Juice For Prostate CancerNational Cancer Institute2005–2008
Dietary Tomato Products And Experimental Prostate CancerNational Cancer Institute1998–1999
Dietary Tomato Products And Experimental Prostate CancerNational Cancer Institute1997
Preventive Oncology Academic AwardNational Cancer Institute1992–1996